Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 168

1.

Effect of adiponectin on cardiac β-catenin signaling pathway under angiotensin II infusion.

Fujishima Y, Maeda N, Matsuda K, Komura N, Hirata A, Mori T, Sekimoto R, Tsushima Y, Nishizawa H, Funahashi T, Shimomura I.

Biochem Biophys Res Commun. 2014 Feb 7;444(2):224-9. doi: 10.1016/j.bbrc.2014.01.043. Epub 2014 Jan 22.

PMID:
24462873
2.

Adiponectin modulates the glycogen synthase kinase-3beta/beta-catenin signaling pathway and attenuates mammary tumorigenesis of MDA-MB-231 cells in nude mice.

Wang Y, Lam JB, Lam KS, Liu J, Lam MC, Hoo RL, Wu D, Cooper GJ, Xu A.

Cancer Res. 2006 Dec 1;66(23):11462-70.

3.

Evidence for the importance of adiponectin in the cardioprotective effects of pioglitazone.

Li P, Shibata R, Unno K, Shimano M, Furukawa M, Ohashi T, Cheng X, Nagata K, Ouchi N, Murohara T.

Hypertension. 2010 Jan;55(1):69-75. doi: 10.1161/HYPERTENSIONAHA.109.141655. Epub 2009 Nov 23.

4.

Lysosomal cysteine peptidase cathepsin L protects against cardiac hypertrophy through blocking AKT/GSK3beta signaling.

Tang Q, Cai J, Shen D, Bian Z, Yan L, Wang YX, Lan J, Zhuang GQ, Ma WZ, Wang W.

J Mol Med (Berl). 2009 Mar;87(3):249-60. doi: 10.1007/s00109-008-0423-2. Epub 2008 Dec 19.

PMID:
19096818
5.

Cardiac-specific Traf2 overexpression enhances cardiac hypertrophy through activating AKT/GSK3β signaling.

Huang Y, Wu D, Zhang X, Jiang M, Hu C, Lin J, Tang J, Wu L.

Gene. 2014 Feb 25;536(2):225-31. doi: 10.1016/j.gene.2013.12.052. Epub 2013 Dec 27.

PMID:
24378234
6.

Angiotensin II increases fibronectin and collagen I through the β-catenin-dependent signaling in mouse collecting duct cells.

Cuevas CA, Gonzalez AA, Inestrosa NC, Vio CP, Prieto MC.

Am J Physiol Renal Physiol. 2015 Feb 15;308(4):F358-65. doi: 10.1152/ajprenal.00429.2014. Epub 2014 Nov 19.

7.

Interruption of Wnt signaling attenuates the onset of pressure overload-induced cardiac hypertrophy.

van de Schans VA, van den Borne SW, Strzelecka AE, Janssen BJ, van der Velden JL, Langen RC, Wynshaw-Boris A, Smits JF, Blankesteijn WM.

Hypertension. 2007 Mar;49(3):473-80. Epub 2007 Jan 8.

8.

Cardiac-specific mindin overexpression attenuates cardiac hypertrophy via blocking AKT/GSK3β and TGF-β1-Smad signalling.

Yan L, Wei X, Tang QZ, Feng J, Zhang Y, Liu C, Bian ZY, Zhang LF, Chen M, Bai X, Wang AB, Fassett J, Chen Y, He YW, Yang Q, Liu PP, Li H.

Cardiovasc Res. 2011 Oct 1;92(1):85-94. doi: 10.1093/cvr/cvr159. Epub 2011 Jun 1.

9.

DKK3 overexpression attenuates cardiac hypertrophy and fibrosis in an angiotensin-perfused animal model by regulating the ADAM17/ACE2 and GSK-3β/β-catenin pathways.

Zhai CG, Xu YY, Tie YY, Zhang Y, Chen WQ, Ji XP, Mao Y, Qiao L, Cheng J, Xu QB, Zhang C.

J Mol Cell Cardiol. 2018 Jan;114:243-252. doi: 10.1016/j.yjmcc.2017.11.018. Epub 2017 Dec 5.

PMID:
29196099
10.

Akt and MAPK signaling mediate pregnancy-induced cardiac adaptation.

Chung E, Yeung F, Leinwand LA.

J Appl Physiol (1985). 2012 May;112(9):1564-75. doi: 10.1152/japplphysiol.00027.2012. Epub 2012 Feb 16.

11.

Angiotensin type 1 receptor mediates thyroid hormone-induced cardiomyocyte hypertrophy through the Akt/GSK-3beta/mTOR signaling pathway.

Diniz GP, Carneiro-Ramos MS, Barreto-Chaves ML.

Basic Res Cardiol. 2009 Nov;104(6):653-67. doi: 10.1007/s00395-009-0043-1. Epub 2009 Jul 9.

PMID:
19588183
12.

Inhibition of Rho-kinase by fasudil attenuated angiotensin II-induced cardiac hypertrophy in apolipoprotein E deficient mice.

Wang YX, da Cunha V, Martin-McNulty B, Vincelette J, Li W, Choy DF, Halks-Miller M, Mahmoudi M, Schroeder M, Johns A, Light DR, Dole WP.

Eur J Pharmacol. 2005 Apr 11;512(2-3):215-22.

PMID:
15840407
13.

C-C Motif Chemokine Receptor 9 Exacerbates Pressure Overload-Induced Cardiac Hypertrophy and Dysfunction.

Xu Z, Mei F, Liu H, Sun C, Zheng Z.

J Am Heart Assoc. 2016 May 4;5(5). pii: e003342. doi: 10.1161/JAHA.116.003342.

14.

β-Adrenergic receptor-PI3K signaling crosstalk in mouse heart: elucidation of immediate downstream signaling cascades.

Zhang W, Yano N, Deng M, Mao Q, Shaw SK, Tseng YT.

PLoS One. 2011;6(10):e26581. doi: 10.1371/journal.pone.0026581. Epub 2011 Oct 19.

15.

Adiponectin is required for cardiac MEF2 activation during pressure overload induced hypertrophy.

Dadson K, Turdi S, Hashemi S, Zhao J, Polidovitch N, Beca S, Backx PH, McDermott JC, Sweeney G.

J Mol Cell Cardiol. 2015 Sep;86:102-9. doi: 10.1016/j.yjmcc.2015.06.020. Epub 2015 Jul 19.

PMID:
26196305
16.

Overexpression of protein phosphatase 2A in a murine model of chronic myocardial infarction leads to increased adverse remodeling but restores the regulation of β-catenin by glycogen synthase kinase 3β.

Hoehn M, Zhang Y, Xu J, Gergs U, Boknik P, Werdan K, Neumann J, Ebelt H.

Int J Cardiol. 2015 Mar 15;183:39-46. doi: 10.1016/j.ijcard.2015.01.087. Epub 2015 Jan 29.

PMID:
25662052
17.

Adiponectin protects against angiotensin II-induced cardiac fibrosis through activation of PPAR-alpha.

Fujita K, Maeda N, Sonoda M, Ohashi K, Hibuse T, Nishizawa H, Nishida M, Hiuge A, Kurata A, Kihara S, Shimomura I, Funahashi T.

Arterioscler Thromb Vasc Biol. 2008 May;28(5):863-70. doi: 10.1161/ATVBAHA.107.156687. Epub 2008 Feb 28.

18.

Fibulin-2 deficiency attenuates angiotensin II-induced cardiac hypertrophy by reducing transforming growth factor-β signalling.

Zhang H, Wu J, Dong H, Khan SA, Chu ML, Tsuda T.

Clin Sci (Lond). 2014 Feb;126(4):275-88. doi: 10.1042/CS20120636.

19.

LEOPARD-type SHP2 mutant Gln510Glu attenuates cardiomyocyte differentiation and promotes cardiac hypertrophy via dysregulation of Akt/GSK-3β/β-catenin signaling.

Ishida H, Kogaki S, Narita J, Ichimori H, Nawa N, Okada Y, Takahashi K, Ozono K.

Am J Physiol Heart Circ Physiol. 2011 Oct;301(4):H1531-9. doi: 10.1152/ajpheart.00216.2011. Epub 2011 Jul 29.

20.

Depletion of mammalian target of rapamycin (mTOR) via siRNA mediated knockdown leads to stabilization of beta-catenin and elicits distinct features of cardiomyocyte hypertrophy.

Hagenmueller M, Malekar P, Fieger C, Weiss CS, Buss SJ, Wolf D, Katus HA, Hardt SE.

FEBS Lett. 2010 Jan 4;584(1):74-80. doi: 10.1016/j.febslet.2009.10.080.

Supplemental Content

Support Center